BACKGROUND AND PURPOSE: Noninvasive imaging identifying a predictive biomarker of the bleeding risk of unruptured intracranial aneurysms (UIAs) is needed. We investigated a potential biomarker of UIA instability, myeloperoxidase, in human aneurysm tissue. METHODS: Human brain aneurysms were harvested after clipping and were histologically and biochemically evaluated for the presence of myeloperoxidase. Of the tissue collected, 3 were from ruptured aneurysms and 20 were from UIAs. For each UIA, its 5-year aneurysm rupture risk was determined using the Population, Hypertension, Age, Size of Aneurysm, Earlier Subarachnoid Hemorrhage From Another Aneurysm and Site of Aneurysm (PHASES) model. RESULTS: All ruptured aneurysms were myeloperoxidase positive. Of the UIAs, half were myeloperoxidase positive. The median 5-year aneurysm rupture risk was higher for myeloperoxidase-positive UIA (2.28%) than myeloperoxidase-negative UIA (0.69%), and the distributions were statistically different (P<0.005, Wilcoxon-Mann-Whitney test). The likelihood for myeloperoxidase-positive UIA was significantly associated (P=0.031) with aneurysm rupture risk (odds ratio, 4.79; 95% confidence limits, 1.15-19.96). CONCLUSIONS: Myeloperoxidase is associated with PHASES estimated risk of aneurysm rupture and may potentially be used as an imaging biomarker of aneurysm instability.
BACKGROUND AND PURPOSE: Noninvasive imaging identifying a predictive biomarker of the bleeding risk of unruptured intracranial aneurysms (UIAs) is needed. We investigated a potential biomarker of UIA instability, myeloperoxidase, in humananeurysm tissue. METHODS:Humanbrain aneurysms were harvested after clipping and were histologically and biochemically evaluated for the presence of myeloperoxidase. Of the tissue collected, 3 were from ruptured aneurysms and 20 were from UIAs. For each UIA, its 5-year aneurysm rupture risk was determined using the Population, Hypertension, Age, Size of Aneurysm, Earlier Subarachnoid Hemorrhage From Another Aneurysm and Site of Aneurysm (PHASES) model. RESULTS: All ruptured aneurysms were myeloperoxidase positive. Of the UIAs, half were myeloperoxidase positive. The median 5-year aneurysm rupture risk was higher for myeloperoxidase-positive UIA (2.28%) than myeloperoxidase-negative UIA (0.69%), and the distributions were statistically different (P<0.005, Wilcoxon-Mann-Whitney test). The likelihood for myeloperoxidase-positive UIA was significantly associated (P=0.031) with aneurysm rupture risk (odds ratio, 4.79; 95% confidence limits, 1.15-19.96). CONCLUSIONS:Myeloperoxidase is associated with PHASES estimated risk of aneurysm rupture and may potentially be used as an imaging biomarker of aneurysm instability.
Authors: Riikka Tulamo; Juhana Frösen; Sami Junnikkala; Anders Paetau; Janne Pitkäniemi; Marko Kangasniemi; Mika Niemelä; Juha Jääskeläinen; Eija Jokitalo; Ayse Karatas; Juha Hernesniemi; Seppo Meri Journal: Neurosurgery Date: 2006-11 Impact factor: 4.654
Authors: Juhana Frösen; Anna Piippo; Anders Paetau; Marko Kangasniemi; Mika Niemelä; Juha Hernesniemi; Juha Jääskeläinen Journal: Stroke Date: 2004-08-19 Impact factor: 7.914
Authors: Jacoba P Greving; Marieke J H Wermer; Robert D Brown; Akio Morita; Seppo Juvela; Masahiro Yonekura; Toshihiro Ishibashi; James C Torner; Takeo Nakayama; Gabriël J E Rinkel; Ale Algra Journal: Lancet Neurol Date: 2013-11-27 Impact factor: 44.182
Authors: Michael J DeLeo; Matthew J Gounis; Bo Hong; John C Ford; Ajay K Wakhloo; Alexei A Bogdanov Journal: Radiology Date: 2009-06-22 Impact factor: 11.105
Authors: Michael Lim; Regina S Bower; Ying Wang; Leroy Sims; Mark R Bower; Joaquin Camara-Quintana; Gordon Li; Samuel Cheshier; Griffith R Harsh; Gary K Steinberg; Samira Guccione Journal: Neurosurg Rev Date: 2012-02-28 Impact factor: 3.042
Authors: V Šćepanović; G Tasić; N Repac; I Nikolić; A Janićijević; D Todorović; M Stojanović; R Šćepanović; D Mitrović; T Šćepanović; S Borozan; Lj Šćepanović Journal: Mol Biol Rep Date: 2018-09-20 Impact factor: 2.316
Authors: Yi Chu; Katina Wilson; He Gu; Lauren Wegman-Points; Sarah A Dooley; Gary L Pierce; Guangjie Cheng; Ricardo A Pena Silva; Donald D Heistad; David Hasan Journal: Stroke Date: 2015-04-28 Impact factor: 7.914
Authors: Matthew J Gounis; Kajo van der Marel; Miklos Marosfoi; Mary L Mazzanti; Frédéric Clarençon; Ju-Yu Chueh; Ajit S Puri; Alexei A Bogdanov Journal: Stroke Date: 2015-09-08 Impact factor: 7.914
Authors: M J Gounis; I M J van der Bom; A K Wakhloo; S Zheng; J-Y Chueh; A L Kühn; A A Bogdanov Journal: AJNR Am J Neuroradiol Date: 2014-10-01 Impact factor: 3.825
Authors: Vincent M Tutino; Kerry E Poppenberg; Kaiyu Jiang; James N Jarvis; Yijun Sun; Ashish Sonig; Adnan H Siddiqui; Kenneth V Snyder; Elad I Levy; John Kolega; Hui Meng Journal: PLoS One Date: 2018-01-17 Impact factor: 3.240